Press releases

Press releases
17th December 2014 - Spinnovation Analytical receives GMP certification for testing drug substances and drug products to support market release



 Spinnovation Analytical receives GMP certification for testing drug substances and drug products to support market release

 17 December 2014: Spinnovation Analytical BV, Oss, The Netherlands: Spinnovation has been granted a certification of Good Manufacturing Practices (GMP) compliance by the Dutch Health Care Inspectorate. This certifies that Spinnovation is qualified to test pharmaceutical drug substances and products for market release. GMP certification is recognition of Spinnovation's adherence to the highest quality management procedures and standards, and will support the company in delivering the QC testing services and analytical solutions for clients involved in the manufacturing and release of small molecule drugs and biologicals.

Sinensis Life Sciences Acquires Spinnovation


NEWS RELEASE | September 19, 2014, Leiden, Oss, the Netherlands (in English)

Sinensis Life Sciences Acquires Spinnovation

Sinensis Life Sciences B.V., Leiden, the Netherlands (“Sinensis”), announces today that it has acquired Spinnovation Holding B.V., Oss, the Netherlands (“Spinnovation”), a contract research organisation specialised in the application of nuclear magnetic resonance (NMR) techniques in the pharmaceutical and biotechnological market. Financial terms of the transaction were not disclosed.



NEWS RELEASE | Nijmegen, 4 July 2011 (in English)
Spedia-NMR™: Breakthrough in Bioprocess Optimization For Biologicals

4th July 2011: Spinnovation, Nijmegen, The Netherlands: For new biologicals and biosimilars, the innovative Spedia-NMR™ technology from Spinnovation Biologics provides a real advantage for optimizing cell cultures , monitoring and standardizing manufacturing processes in preparation for larger scale production. Within the past four months, this has been validated by 37 companies developing biologics or delivering services to this industry.

Spinnovation Biologics

NEWS RELEASE | Nijmegen, 7 April 2011 (in English)

Spinnovation launch new biologics division with unique service provision

 7 April 2011: Spinnovation, Nijmegen, The Netherlands: On 7 April 2011, Frederic Girard, CEO of integrated NMR specialists, Spinnovation Analytical BV (Nijmegen, The Netherlands), announced the launch of a new division of the company – Spinnovation Biologics – at the annual meeting of the Flanders Biotech group.


Press Release | Eindhoven, 23 December 2008 (in dutch)

Innovatieve aanpak gaat diabetes vroegtijdig opsporen 19 miljoen euro voor ontwikkeling nieuwe medische technologieën

<< Start < Prev 1 2 Next > End >>

Page 1 of 2

Spinnovation Analytical is part of Sinensis Life Sciences

visit website x